2013
DOI: 10.1016/j.joms.2013.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Tooth Extractions in Intravenous Bisphosphonate-Treated Patients: A Refined Protocol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0
7

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(57 citation statements)
references
References 26 publications
0
50
0
7
Order By: Relevance
“…All these protocols share antibiotic therapy and differ for the exploitation of some surgical procedures (such as the removal of the alveolar bone all around the socket and the creation of tension-free mucoperiosteal flap for wound closure) [6] or of some adjuvant therapies (e.g., ozone or platelet-rich derivates) [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…All these protocols share antibiotic therapy and differ for the exploitation of some surgical procedures (such as the removal of the alveolar bone all around the socket and the creation of tension-free mucoperiosteal flap for wound closure) [6] or of some adjuvant therapies (e.g., ozone or platelet-rich derivates) [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…The use of autologous growth factors has been proposed as an interesting alternative to the prevention and treatment of BRONJ [11][12][13]. Assuming that BRONJ is characterized by a delayed oral wound healing, the use of a cocktail of proteins and growth factors [14,15] might mitigate some of the negative effects of bisphosphonates and promote key biological step including cell proliferation, migration, and cell viability.…”
Section: Introductionmentioning
confidence: 99%
“…Hareketli protez kullanım-ının bu insidansı artırtığı da bildirilmektedir 60 . Vahtsevanos ve ark'ları IV zolendronat, ibandronat veya pamidronat kullanan 1,621 kanser hastasında hareketli protez kullanımının bu riski 2 kat arrtırdığını bildirmektedir 40 .…”
Section: Ri̇sk Faktörleri̇unclassified
“…Bununla birlikte, hiperbarik oksijen tedavisinin osteonekroz alanının tamamen yumuşak doku ile örtülmesinde tek başına etkisinin olmaması nedeniyle, ilave bir tedavi seçeneği olduğu da belirtilmektedir 83,84 . Diğer cerrahi olmayan tedavi seçenekleri ise; trombositçe zengin plazma 60,85,86 , düşük doz lazer 68 , 24,25,90,91 . Hastalığın evresine bakılmak-sızın, hareketli kemik sekestrları yumuşak doku iyileşmesinin sağlanabilmesi için mutlaka çıkartılma-lıdır.…”
Section: Tedavi̇unclassified